Roland Rutschmann
Fortune : 28 M $ au 30/09/2026
Fortune : 28 M $ au 30/09/2026
Roland Rutschmann currently works at Curatis Holding AG, as Chief Executive Officer & Executive Director from 2024.
Mr. Rutschmann also formerly worked at Actelion Ltd., as Vice President-Strategic Marketing & GM and Orphan Europe SARL, as General Manager from 2009 to 2011.
Mr. Rutschmann received his doctorate degree from the University of Basel.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
23,43 % | 31/12/2025 | 1 245 000 ( 23,43 % ) | 28 M $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|
| Sociétés | Poste | Fin |
|---|---|---|
Orphan Europe SARL
Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Develops and distributes orphan drugs for the treatment of rare diseases and metabolic disorders | Corporate Officer/Principal | 01/01/2011 |
| ACTELION | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orphan Europe SARL
Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Develops and distributes orphan drugs for the treatment of rare diseases and metabolic disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national